Identification of a Mouse Thiamine Transporter Gene as a Direct Transcriptional Target for p53*

p53 tumor suppressor is a transcription factor that functions, in part, through many of its downstream target genes. We have identified a p53-inducible gene by performing mRNA differential display on IW32 murine erythroleukemia cells containing a temperature-sensitive p53 mutant allele, tsp53Val-135. Sequence analysis of the full-length cDNA revealed its identity as the mouse homologue of the human thiamine transporter 1 (THTR-1). Induction of the mouse THTR-1 (mTHTR-1) mRNA was detectable as early as 1 h at 32.5 °C; upon shifting back to 38.5 °C, mTHTR-1 transcript was rapidly degraded with a half-life of less than 2 h. Elevation of mTHTR-1 expression was found in DNA damage-induced normal mouse embryonic fibroblast cells, but not in p53−/−mouse embryonic fibroblast cells, suggesting that mTHTR-1 induction was p53-dependent. A region within the first intron of the mTHTR-1 gene bound to p53 and conferred the p53-mediated transactivation. Furthermore, increased thiamine transporter activities were found in cells overexpressing mTHTR-1 and under conditions of DNA damage or p53 activation. Our findings indicate that p53 may be involved in maintaining thiamine homeostasis through transactivation of THTR-1.

[1]  W. Maltzman,et al.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.

[2]  A. Levine,et al.  Tumor-suppressor p53 and the cell cycle. , 1993, Current opinion in genetics & development.

[3]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[4]  M. Swaroop,et al.  Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53* , 1999, The Journal of Biological Chemistry.

[5]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[6]  M. V. Heiden,et al.  Redox regulation of p53 during hypoxia , 2000, Oncogene.

[7]  M. Oren,et al.  p53 in growth control and neoplasia. , 1996, Biochimica et biophysica acta.

[8]  P. Hanawalt,et al.  Expression of Wild-type p53 Is Required for Efficient Global Genomic Nucleotide Excision Repair in UV-irradiated Human Fibroblasts* , 1997, The Journal of Biological Chemistry.

[9]  V. Ganapathy,et al.  Molecular cloning of the human placental folate transporter. , 1995, Biochemical and biophysical research communications.

[10]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[11]  V. Ganapathy,et al.  Cloning of the Human Thiamine Transporter, a Member of the Folate Transporter Family* , 1999, The Journal of Biological Chemistry.

[12]  N. Chandel,et al.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Gelb,et al.  Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome , 1999, Nature Genetics.

[14]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[15]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[16]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[17]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[18]  K. Cowan,et al.  A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates. , 1984, The Journal of biological chemistry.

[19]  M L Agarwal,et al.  The p53 Network* , 1998, The Journal of Biological Chemistry.

[20]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[21]  W. Flintoff,et al.  Structural Organization of the Reduced Folate Carrier Gene in Chinese Hamster Ovary Cells* , 1996, The Journal of Biological Chemistry.

[22]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. L. Witt,et al.  Repression of Human Reduced Folate Carrier Gene Expression by Wild Type p53* , 2001, The Journal of Biological Chemistry.

[24]  A. Fornace,et al.  The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  D. Lazarević,et al.  A novel p53‐inducible gene coding for a microtubule‐localized protein with G2‐phase‐specific expression , 1998, The EMBO journal.

[26]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[27]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[28]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[29]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[30]  O. Halevy,et al.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.

[31]  H. Friess,et al.  The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract , 1999, Oncogene.

[32]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[33]  Pang-Kuo Lo,et al.  Identification of a novel mouse p53 target gene DDA3 , 1999, Oncogene.

[34]  J. Shay,et al.  A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.

[35]  F. Wang,et al.  Protein tyrosine phosphatase-dependent activation of beta-globin and delta-aminolevulinic acid synthase genes in the camptothecin-induced IW32 erythroleukemia cell differentiation. , 1997, Molecular pharmacology.

[36]  S. Eng,et al.  Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. , 1991, Cancer communications.

[37]  R. Berger,et al.  Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway , 1996, Nature Genetics.

[38]  Timothy Barrett,et al.  Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness , 1999, Nature Genetics.

[39]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[40]  K. Cowan,et al.  A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. , 1994, The Journal of biological chemistry.

[41]  Yusuke Nakamura,et al.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage , 2000, Nature.

[42]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[43]  G. Vile.  Active oxygen species mediate the solar ultraviolet radiation‐dependent increase in the tumour suppressor protein p53 in human skin fibroblasts , 1997, FEBS letters.

[44]  Pi-Pei Tang,et al.  Induction of IW32 erythroleukemia cell differentiation by p53 is dependent on protein tyrosine phosphatase , 2000, Leukemia.

[45]  D. Lane,et al.  Regulation of the specific DNA binding function of p53 , 1992, Cell.

[46]  A. Hazell,et al.  Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: An in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy , 2000, Journal of neuroscience research.

[47]  Ellis J. Neufeld,et al.  The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter , 1999, Nature Genetics.

[48]  K. McLure,et al.  How p53 binds DNA as a tetramer , 1998, The EMBO journal.

[49]  J. Sun,et al.  Role of antioxidant enzymes on ionizing radiation resistance. , 1998, Free radical biology & medicine.

[50]  G. Hannon,et al.  Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair , 1994, Nature.

[51]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[52]  T. Galeotti,et al.  Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. , 2000, Cancer research.

[53]  W. Flintoff,et al.  Isolation of a Human cDNA That Complements a Mutant Hamster Cell Defective in Methotrexate Uptake (*) , 1995, The Journal of Biological Chemistry.

[54]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.